MHIC
FMTX

Marble Harbor Investment Counsel’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Marble Harbor Investment Counsel’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,864
Closed -$420K – 196
2021
Q2 		$420K Sell
16,864
-7,000
-29% -$188K 0.05% 137
2021
Q1 		$669K Sell
23,864
-2,000
-8% -$72.2K 0.09% 107
2020
Q4 		$903K Buy
+25,864
New +$1.13M 0.13% 91

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Marble Harbor Investment Counsel's FMTX Position: Q3 2021 in Review

Marble Harbor Investment Counsel sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2021, closing a stake of 16,864 shares — an estimated $420K sold.

Marble Harbor Investment Counsel first reported a position in FMTX in Q4 2020 and held it in 3 quarters. The position peaked at $903K in Q4 2020. 89 funds tracked by Wall St. Rank hold FMTX as of Q3 2021.

  • Marble Harbor Investment Counsel reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Marble Harbor Investment Counsel sold 16,864 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2021, an estimated $420K.
  • Marble Harbor Investment Counsel first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Marble Harbor Investment Counsel's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $903K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2021.

Based on Marble Harbor Investment Counsel's 13F filing for Q3 2021, filed 10 Nov 2021.